The UK Government has launched a review of business-university growth opportunities, led by GlaxoSmithKline chief executive Sir Andrew Witty.

The report aims to address failings in the UK to commercialise university research by cultivating links with more local businesses surround the UK’s research hubs.

Sir Witty, who is also chancellor of the University of Nottingham, said: “It is vitally important that the world-leading capabilities in our universities and research base are at the heart of both the industrial strategy and…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?